CT
Cantabio Pharmaceuticals, Inc.
CTBO · OTC
$1.01 +0.00% (+$0.00)
Valuation
-
N/A PEG N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 456.60x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CTBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gergely Tóth
Employees
451
Headquarters
Palo Alto